Analystreport

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) was upgraded by analysts at Barclays PLC from an "underweight" rating to an "equal weight" rating. They now have a $52.0

Ionis Pharmaceuticals, Inc.  (IONS) 
Last ionis pharmaceuticals, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ionispharma.com